| SYNTHAVERSE S.A. ZY-,10 |
| Polen |
| Gesundheit |
| PLBMDLB00018 / A1J10U |
| 6NQ (Frankfurt) |
| FRA:6NQ, ETR:6NQ, 6NQ:GR |
| - |
| https://synthaverse.com/ |
|
Synthaverse S.A., an influential player in the technology and entertainment sector, is known for its groundbreaking work in the field of virtual and augmented reality. As a creator and distributor of immersive experiences, Synthaverse S.A. focuses on..
>Volltext.. |
| 63.86 Mio. EUR |
| 83.99 Mio. EUR |
| 12.77 Mio. EUR |
| 2.28 Mio. EUR |
| -1.44 Mio. EUR |
| -0.02 EUR |
| 20.8 Mio. EUR |
| 0.08 Mio. EUR |
| -0.36 Mio. EUR |
| 0.01 |
| -14.21% |
| -236.26% |
| - |
| - |
| - |
| - |
| SYNTHAVERSE, BIOMED-LUBLIN, BIOMEDLUBLIN, BIOMED LUBLIN |
| 01.04.26 |
|